Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancerTomohiro Kaku, Akihiro Tasaka, Mari Adachi et al.|Bioorganic & Medicinal Chemistry|2011Cited by 126
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeysMasuo Yamaoka, Masami Kusaka, Takahito Hara et al.|The Journal of Steroid Biochemistry and Molecular Biology|2012Cited by 116